M

Moderna

Develops mRNA-based medicines for health

Executive Director - INT Oncology Marketing

Product MarketingUpdated on Nov 8
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 12 years of progressive marketing experience within the biopharmaceutical or biotechnology industry is required.
  • Proven leadership of multiple oncology brands or franchises, including significant U.S. oncology commercialization experience, is required.
  • Experience launching brands outside the United States is required.
  • Strong presentation, communication, collaboration, and stakeholder-management skills are required.
  • Ability to travel 20% or more is required.
  • Oncology launch experience, particularly recent experience in U.S. or global markets, is required.
  • A master's degree in an associated business or science discipline is a plus.
  • Experience executing in an alliance relationship is preferred.
  • Melanoma or non-small cell lung cancer experience is strongly preferred.
  • Experience working in a solution-oriented, dynamic startup environment is preferred.

Responsibilities

  • Own development of brand positioning, messaging, and competitive strategy for all lifecycle indications, establishing a differentiated commercial narrative for intismeran autogene and its potential role across diverse tumor types.
  • Shape and actualize U.S. and ex-U.S. commercial strategy for the intismeran portfolio across marketed and potential indications, leading strategy for all indications outside adjuvant melanoma in close collaboration with the alliance partner.
  • Oversee customer and market insight generation with the alliance partner through primary and secondary market research, competitive intelligence, advisory boards, and other evidence sources that inform strategic decisions.
  • Establish a multi-year strategic roadmap spanning marketed products and pipeline indications, translating lifecycle opportunities into sequenced commercial priorities and execution plans.
  • Lead scenario planning, risk management, and contingency strategy for future launches, including integration of commercial forecasting and supply chain coordination.
  • Shape prioritization, resource allocation, and investment planning across future commercial opportunities.
  • Translate commercial strategy, evolving product profiles, clinical evidence, and Moderna’s scientific platforms into actionable go-to-market strategies.
  • Lead selected strategic initiatives across the brand in the United States and ex-U.S., moving between long-term strategy development and detailed execution.
  • Partner with Sales, Commercial Operations, Clinical Development, Medical Affairs, Market Access and Value Creation, Finance, Regulatory, Legal, and other oncology stakeholders, including the alliance partner, to deliver the brand’s ambitions.
  • Identify capability-development opportunities within Sales and the broader commercial organization, and develop tools, resources, and approaches to strengthen team skills and readiness for future indications and launches.
  • Help build the commercial foundations for Moderna’s expansion into cancer therapeutics and contribute to launching a personalized mRNA oncology program designed around each patient’s tumor profile.
  • Explore use of generative artificial intelligence and emerging digital tools for insight synthesis, scenario development, competitive assessment, content development, and commercial decision-making within appropriate governance and compliance frameworks.

Desired Qualifications

  • Strong adaptability and an ownership mindset in a highly dynamic environment.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs